Delivery Order SPE2DB22D1202-SPE2DB24FVBM6
- Not listed
- The federal contract award is for the delivery of Insulin Aspart 100 Unit/mL Vial 10mL to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,545.06 and a completion date of July 11, 2025. The contract is a Firm Fixed Price Delivery Order, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set-aside and allows for open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of Insulin Aspart 100 Unit/ML Pen 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $8,765.68, was granted to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 1, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of 10 ml vials of Insulin Aspart 100 Unit/ml. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $7,692.48 and is a firm fixed price delivery order. This award appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to...
- This federal contract award is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL, a critical pharmaceutical product, to the U.S. government. The $14,535.08 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of September 9, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
- This federal contract award is for the delivery of 10 milliliter vials of insulin aspart 100 unit/milliliter. The award, with a ceiling value of $1,738.30, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order and has a firm fixed price pricing type, with a period of performance extending to July 10, 2023. The contract was not set aside for any specific type of business. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,641.34, is for the delivery of 4564186129 Insulin Aspart 100 Unit/mL Vial 10mL. The contract has a firm fixed price and an ultimate completion date of April 8, 2024. The contract is a delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a...
- This federal contract award is for the delivery of Insulin Aspart 100 Unit/mL Vials (10 mL) to the Defense Logistics Agency (DLA). The contract, valued at $2,250.10, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 22, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This federal contract award is for the delivery of insulin aspart 100 unit/ml pen, 3 ml, to the Defense Logistics Agency (DLA). The $4,863.40 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a period of performance through January 11, 2024 and was not set aside for any specific small business designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $2,603.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564943786 - Insulin Aspart 100 Unit/mL in 10mL vials, with a completion date of June 20, 2024. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, valued at $3,764.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin aspart 100 unit/mL pens. The contract is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FVBM6Delivery Order
This federal contract award is for the delivery of Insulin Aspart 100 Unit/mL vials with a 10 mL volume, valued at $1,272.60. The award was made by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific award is not designated as a set-aside contract. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 5/28/24 |